AR046921A1 - Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes - Google Patents
Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantesInfo
- Publication number
- AR046921A1 AR046921A1 ARP040103962A ARP040103962A AR046921A1 AR 046921 A1 AR046921 A1 AR 046921A1 AR P040103962 A ARP040103962 A AR P040103962A AR P040103962 A ARP040103962 A AR P040103962A AR 046921 A1 AR046921 A1 AR 046921A1
- Authority
- AR
- Argentina
- Prior art keywords
- incorporation
- external membrane
- antigens
- bacteria
- vesicules
- Prior art date
Links
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title abstract 2
- 238000010348 incorporation Methods 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Método para la incorporacion de antígenos proteicos naturales, recombinantes o sintéticos en un preparado de vesículas de membrana externa de bacterias Gram negativas, sin producir ruptura de la estructura vesicular, manteniendo la inmunogenicidad y la capacidad inmunoestimuladora de las mismas, con la ventaja de que se genera contra el antígeno incorporado una respuesta inmune superior a la generada contra el antígeno administrado solo. Las composiciones vacunales resultantes son utiles para elevar el espectro protector de vacunas ya existentes y permiten extenderlo contra diferentes patogenos en enfermedades bacterianas, virales, cancerosas, o de otro origen. Las composiciones referidas son aplicables en la industria farmacéutica como vacunas para uso profiláctico y terapéutico en humano.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20030254A CU23377A1 (es) | 2003-11-04 | 2003-11-04 | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046921A1 true AR046921A1 (es) | 2006-01-04 |
Family
ID=34529418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103962A AR046921A1 (es) | 2003-11-04 | 2004-10-29 | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070166333A1 (es) |
| EP (1) | EP1688428A1 (es) |
| AR (1) | AR046921A1 (es) |
| AU (1) | AU2004284969A1 (es) |
| BR (1) | BRPI0416178A (es) |
| CA (1) | CA2543206A1 (es) |
| CU (1) | CU23377A1 (es) |
| NZ (1) | NZ547519A (es) |
| WO (1) | WO2005042571A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0913268A2 (pt) | 2008-05-30 | 2016-03-15 | U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army | vacina de vesícula de membrana externa nativa multivalente meningocócica, métodos de fabricação e uso da mesma |
| WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
| JP5818793B2 (ja) | 2009-09-01 | 2015-11-18 | イオン メディックス インコーポレイテッド | 腸内共生細菌由来細胞外ベシクル、並びにこれを用いた疾病モデル、ワクチン、候補薬物探索方法及び診断方法 |
| BR102020013216A2 (pt) * | 2020-06-26 | 2022-03-08 | Instituto Butantan | Processo de obtenção de vesículas apresentadoras de antígenos (vaa) que possibilita o acoplamento de um ou mais antígenos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| NO20002828D0 (no) * | 2000-06-02 | 2000-06-02 | Statens Inst For Folkehelse | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
| GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
-
2003
- 2003-11-04 CU CU20030254A patent/CU23377A1/es unknown
-
2004
- 2004-10-29 AR ARP040103962A patent/AR046921A1/es unknown
- 2004-11-03 AU AU2004284969A patent/AU2004284969A1/en not_active Abandoned
- 2004-11-03 US US10/577,000 patent/US20070166333A1/en not_active Abandoned
- 2004-11-03 WO PCT/CU2004/000012 patent/WO2005042571A1/es active Application Filing
- 2004-11-03 CA CA002543206A patent/CA2543206A1/en not_active Abandoned
- 2004-11-03 NZ NZ547519A patent/NZ547519A/en unknown
- 2004-11-03 EP EP04797391A patent/EP1688428A1/en not_active Withdrawn
- 2004-11-03 BR BRPI0416178-5A patent/BRPI0416178A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070166333A1 (en) | 2007-07-19 |
| WO2005042571A1 (es) | 2005-05-12 |
| AU2004284969A1 (en) | 2005-05-12 |
| NZ547519A (en) | 2009-01-31 |
| CA2543206A1 (en) | 2005-05-12 |
| EP1688428A1 (en) | 2006-08-09 |
| BRPI0416178A (pt) | 2007-01-09 |
| CU23377A1 (es) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2331952T3 (es) | Fraccion de quil a con baja toxicidad y su uso. | |
| NO20015073L (no) | Vaksiner | |
| NI202000040A (es) | Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| HUP0101619A2 (hu) | Adjuvánskészítmények | |
| BR112013009649A2 (pt) | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição | |
| TW200722101A (en) | Novel composition | |
| MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
| JP2012021028A5 (es) | ||
| ES2853773T3 (es) | Procedimientos novedosos para inducir una respuesta inmune | |
| ES2307402B1 (es) | Vacuna profilactica contra la tuberculosis. | |
| ES2320971T3 (es) | Arqueosomas como adjuvantes y vehiculos para vacunas acelulares para inducir respuestas de linfocitos t cototoxicos. | |
| DE60331412D1 (de) | Hiv-vakzine und anwendungsverfahren | |
| Simerska et al. | Oral vaccine delivery-new strategies and technologies | |
| AR039982A1 (es) | Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas | |
| Abedi et al. | Rabies vaccine: Recent update and comprehensive review of in vitro and in vivo studies | |
| Duong et al. | Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant | |
| AR046921A1 (es) | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes | |
| NO20045587L (no) | Liposom vaksineformulering for finne-fisk | |
| EP3076997A1 (en) | Swine vaccine against prrs and lawsonia intracellularis | |
| BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
| Li et al. | The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis | |
| CN114366810A (zh) | 一种可高效诱导体液和细胞免疫的天然微生物和植物来源复合双佐剂及其制备方法和应用 | |
| MY127452A (en) | Vaccines. | |
| AR046937A1 (es) | Proteina nmb0928 y su uso en formulaciones farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |